DiaMedica Therapeutics, Inc. (DMAC)
8.25
+0.23
(+2.87%)
USD |
NASDAQ |
Nov 20, 16:00
8.255
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Cash and Short Term Investments (Annual) : 59.89M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 59.89M |
| December 31, 2024 | 44.15M |
| December 31, 2023 | 52.90M |
| December 31, 2022 | 33.50M |
| December 31, 2021 | 45.11M |
| December 31, 2020 | 27.51M |
| December 31, 2019 | 7.878M |
| December 31, 2018 | 16.82M |
| December 31, 2017 | 1.353M |
| December 31, 2016 | 1.736M |
| December 31, 2015 | 0.1655M |
| Date | Value |
|---|---|
| December 31, 2014 | 0.2042M |
| December 31, 2013 | 2.527M |
| December 31, 2012 | 2.338M |
| December 31, 2011 | 2.659M |
| December 31, 2010 | 2.855M |
| December 31, 2009 | 0.6288M |
| December 31, 2008 | 2.433M |
| December 31, 2007 | 3.514M |
| December 31, 2006 | 0.27M |
| December 31, 2005 | 0.2732M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.193B |
| Nektar Therapeutics | 245.75M |
| Fortress Biotech, Inc. | 79.38M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |